Suzetrigine, a new non-opioid pain relief drug sold under the brand name Journavx marks the first new class of pain reliever to receive FDA approval in over two decades.
Journavx, New Type Of Non-Opioid Pain Relief Drug Gets FDA Approval
by | Feb 2, 2025 | Uncategorized | 0 comments
Recent Comments